FDA Inspection
Shilpa Medicare LimitedShilpa Medicare Limited – FDA Inspection, Jul 28, 2017
Record Details
This FDA Inspection record concerns Shilpa Medicare Limited, with an inspection on July 28, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 3ddb8f78-d603-4012-b674-1b39a9477513
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1020609
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Shilpa Medicare Limited
7| Date | Classification | Office | Project area |
|---|---|---|---|
| November 21, 2025 | Not classified | Office of Inspections and Investigations | |
| November 9, 2023 | Not classified | Office of Inspections and Investigations | |
| February 25, 2020 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 6, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 30, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Shilpa Medicare Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.